Construct and concurrent validation of the MG-QOL15 in the practice setting

Muscle and Nerve

Volumn 41, Issue 2, 2010, Pages 219-226

  Burns, Ted M ^a,b   Grouse, C K ^a   Conaway, Mark R ^a,b   Sanders, Donald B ^a,d   Solorzano, Guillermo ^b   Farrugia, Maria E ^c   Massey, Janice M ^d   Juel, Vern C ^d   Hobson Webb, Lisa D ^d   Tucker Lipscomb, Bernadette ^d   Antozzi, Carlo ^e   Mantegazza, Renato ^e   Lacomis, David ^f   Dimberg, Elliot ^g   Muppidi, Srikanth ^h   Wolfe, Gil ^h   Dimachkie, Mazen M ⁱ   Barohn, Richard J ⁱ   Pasnoor, Mamatha ⁱ   McVey, April L ⁱ   Herbelin, Laura ⁱ   Mozaffar, Tahseen ^j   Dang, Vinh Q ^j   Rao, Sandhya ^j   Pascuzzi, Robert ^k   Snook, Riley ^k   Amato, Anthony A ^l   more..

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c INSTITUTE OF NEUROLOGICAL SCIENCES   (United Kingdom)

^d DUKE UNIVERSITY   (United States)

^e DEPARTMENT OF NEUROSURGERY   (Italy)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF TEXAS   (United States)

ⁱ UNIVERSITY OF KANSAS   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k INDIANA UNIVERSITY   (United States)

^l HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

15 item myasthenia gravis quality of life scale (MG QOL15); Construct validity; Health related quality of life (HRQOL); Myasthenia gravis

Indexed keywords

ARTICLE; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; MYASTHENIA GRAVIS COMPOSITE SCALE; MYASTHENIA GRAVIS QUALITY OF LIFE SCALE 15; MYASTHENIA GRAVIS SPECIFIC ACTIVITIES OF DAILY LIVING SCALE; MYASTHENIA GRAVIS SPECIFIC MANUAL MOTOR TEST; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REMISSION; SCORING SYSTEM;

DISABILITY EVALUATION; HEALTH SURVEYS; HUMANS; MYASTHENIA GRAVIS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENTS; PROFESSIONAL PRACTICE; PSYCHOMETRICS; QUALITY OF LIFE; SELF CONCEPT; SEVERITY OF ILLNESS INDEX;

EID: 76649096304     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21609     Document Type: Article

References (17)

1. Ebrahim S. Clinical and public health perspectives and applications of health-related quality of life measurement. Soc Sci Med 1995;41:1383-1394.
2. Cella DF, Tulsky DS. Measuring quality of life today: methodological aspects. Oncology 1990;4:29-38.
3. Padua L, Evoli A, Aprile I, Caliandro P, Batocchi AP, Punzi C, et al. Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire. Neurol Sci 2002; 23:59-68.
4. Mullins LL, Carpentier MY, Paul RH, Sanders DB, Muscle Study Group. Disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve 2008;38:947-956.
5. Calman KC. Quality of life in cancer patients-an hypothesis. J Med Ethics 1984;10:124-127.
6. Farquhar M. Elderly people's definitions of quality of life. Soc Sci Med 1995;41:1439-1446.
7. The WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995;41:1403-1409.
8. Burke LB, Kennedy DL, Miskal PH, Papadopoulos EJ, Trentacosti AM. The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clin Pharm Ther 2008;84:281-283.
9. Hobart JC, Cano SJ, Zajicek JP, Thompson AJ. Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol 2007;6:1094-1105.
10. Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis. Muscle Nerve 2008;38:957-963.
11. Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group. Construction of an efficient evaluative instrument for myasthenia gravis: the MG Composite. Muscle Nerve 2008;38:1553-1562.
12. Muscle Study Group. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. Neurology 2008;71:394-399.
13. Wolfe GI, Herbelin LR, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology 1999;52:1487-1489.
14. Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the quantitative myasthenia gravis score. Ann N Y Acad Sci 1998;841:769-772.
15. Sanders DB, Tucker-Lipscomb B, Massey JM. A simple manual muscle test for myasthenia gravis: Validation and comparison with the QMG score. Ann N Y Acad Sci 2003;998:440-444.
16. Jaretzki A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al., for the Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Myasthenia gravis: recommendations for clinical research standards. Neurology 2000;55:16-23.
17. Neter J, Kutner M, Nachtsheim C, Wasserman W. Applied linear statistical models, 4th ed. Chicago: Irwin Publishers; 1996.